Clin2
NCT05984758Possibly a fitNot yet recruiting

Better Eye Screening for Children with JIA

Uveitis, AnteriorJuvenile Idiopathic Arthritis

Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Skin clinical trials.

This study uses a special imaging test (not the standard flashlight exam) to screen for eye inflammation (uveitis) in children with juvenile idiopathic arthritis. It aims to see if this new method is better at catching uveitis early.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
2 years to 12 years
Study type
Interventional

Who can take part

  • Your child was diagnosed with JIA in the last year and needs regular eye checks for uveitis.
  • Your child is between 2 and 12 years old.
  • Your child has never had uveitis before.
  • Your child has no other eye or brain conditions that affect vision now or could in the future.
  • Your child can cooperate with an eye exam and understand the process.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06007456Recruiting
Study of Juvenile Idiopathic Arthritis in Children

This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.

Trieste
NCT07699107Not yet recruiting· Phase 4
Adjusting adalimumab dose for children with eye inflammation

This trial tests whether adjusting the dose of adalimumab (a medicine used to treat inflammation) can keep eye inflammation under control in children with juvenile idiopathic arthritis or chronic anterior uveitis. If you or your child have had stable eye inflammation for at least 2 years while on adalimumab, this study may help find the best long-term dose.

Los Angeles, California
NCT04833465Recruiting
Testing a new outcome measure in kids with rheumatology diseases

This study looks at how to measure treatment success in children with juvenile idiopathic arthritis (JIA), lupus (SLE), or fibromyalgia (FM). It may help doctors track symptoms more reliably over time.

Washington D.C., District of Columbia
NCT07517575Recruiting· Phase 2
Olokizumab for Children with Juvenile Idiopathic Arthritis

This trial tests a new medicine called olokizumab in children and teenagers with juvenile idiopathic arthritis (JIA)—a condition where the immune system causes joint inflammation and pain. The study checks if this drug is safe and effective for children whose arthritis hasn't improved enough with standard treatments.

Kazan'
NCT07065747Recruiting
Understanding inflammation in uveitis using advanced eye imaging

This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.

Portland, Oregon
NCT07518134Recruiting
Understanding Uveitis in Children Under 18

This study looks at uveitis, a type of eye inflammation, in children. Researchers want to learn more about different types of uveitis and how they affect children, whether the inflammation is new or has been going on for a while.

Boston, Massachusetts

Hear when a new Uveitis, Anterior trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.